Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
11,331 Dovepress* 5,939 1,629+ 1,430 7,568
PubMed Central* 0 3,763 1,031 3,763
Totals 5,939 5,392 2,461 11,331
*Since 7 December 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 2 3

View citations on PubMed Central and Google Scholar